These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9523057)

  • 21. Rizatriptan versus usual care in long-term treatment of migraine.
    Silberstein SD
    Neurology; 2000; 55(9 Suppl 2):S25-8. PubMed ID: 11089516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
    Mayo KW; Osterhaus JT
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Self assessment quality of life and lung diseases (SAQOL in patients with pulmonary carcinoma: influence to survival and impact of chronic obstructive pulmonary disease].
    Grahmann PR; Crockett AJ
    Pneumologie; 2005 Jul; 59(7):446-55. PubMed ID: 16047278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Validation of the combined SF36/MSQOL test of evaluation of quality of life in migraine patients in France].
    Gerbaud L; Navez ML; Couratier P; Lejeune ML; Vernay D; Aufauvre D; Preux PM; Metz O; Dazord A; Laurent B; Clavelou P
    Rev Neurol (Paris); 2002 Jul; 158(6-7):719-27. PubMed ID: 12486902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disability and quality of life in different primary headaches: results from Italian studies.
    Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
    Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: comparison with episodic migraine.
    Canuet L; Ishii R; Fernandez-Concepcion O; Iwase M; Takeda M
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):738-40. PubMed ID: 19068012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The migraine cycle: patient burden of migraine during and between migraine attacks.
    Brandes JL
    Headache; 2008 Mar; 48(3):430-41. PubMed ID: 18179565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of needs-based quality of life instruments.
    Doward LC; McKenna SP; Meads DM
    Value Health; 2004; 7 Suppl 1():S35-8. PubMed ID: 15367243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of drug therapy on quality of life in headache and migraine.
    Solomon GD; Litaker DG
    Pharmacoeconomics; 1997 Apr; 11(4):334-42. PubMed ID: 10166407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Winning a sweepstakes does not cure migraine.
    Evans RW
    Headache; 1995 Mar; 35(3):169. PubMed ID: 7721581
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessing health-related quality of life in patients with migraine.
    Becker WJ
    Can J Neurol Sci; 2002 Jun; 29 Suppl 2():S16-22. PubMed ID: 12139081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.
    Jhingran P; Davis SM; LaVange LM; Miller DW; Helms RW
    Pharmacoeconomics; 1998 Jun; 13(6):707-17. PubMed ID: 10179706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL.
    Wagner TH; Patrick DL; Galer BS; Berzon RA
    Headache; 1996 Sep; 36(8):484-92. PubMed ID: 8824004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meeting patient expectations in migraine treatment: what are the key endpoints?
    Antonaci F; Sances G; Guaschino E; De Cillis I; Bono G; Nappi G
    J Headache Pain; 2008 Aug; 9(4):207-13. PubMed ID: 18607535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of treatments for migraine on quality of life: literature integrative review].
    Stefane T; Napoleão AA; Sousa FA; Hortense P
    Rev Bras Enferm; 2012; 65(2):353-60. PubMed ID: 22911421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.